Analyst Ratings for Altimmune (ALT)
ALT Rating Summary
ALT Price Target Summary
- Highest: $28.00 (Jefferies)
- Lowest: $2.50 (Goldman Sachs)
- Average: $15.85
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$15.85 (+452.3%)
* Over Last 12-Mos
Rating Score: 8.1 / 10
Percentile Rank: 84%
Avg. $ Target:
$15.85 (+452.3%)
* Over Last 12-Mos
Rating Score: 8.1 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/22/2026 | Leerink | N/A | New Coverage | Outperform (N/A) |
10.00 (N/A) |
2.70 (2.87) |
6.3% | Details |
| 4/24/2026 | Goldman Sachs | Corinne Johnson | Upgrade | Neutral (Sell) |
2.50 (N/A) |
2.89 (2.87) |
-0.69% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
